Effect of adjuvant composition on immune response to a multiple antigen peptide (MAP) containing a protective epitope from Neisseria meningitidis class 1 porin. (Q40796063)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Effect of adjuvant composition on immune response to a multiple antigen peptide (MAP) containing a protective epitope from Neisseria meningitidis class 1 porin.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10501243%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

Effect of adjuvant composition on immune response to a multiple antigen peptide (MAP) containing a protective epitope from Neisseria meningitidis class 1 porin (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10501243%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

Neisseria meningitidis

1 reference

based on heuristic

inferred from title

Myron Christodoulides

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10501243%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

author name string

E Rattue

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10501243%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

J E Heckels

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10501243%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

language of work or name

0 references

publication date

1 August 1999

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10501243%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

number of pages

9

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10501243%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

18

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10501243%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1-2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10501243%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

131-139

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10501243%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900190-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900190-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy, safety, and immunogenicity of a meningococcal group B (15:P1.3) outer membrane protein vaccine in Iquique, Chile. Chilean National Committee for Meningococcal Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900190-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunogenicity of two efficacious outer membrane protein-based serogroup B meningococcal vaccines among young adults in Iceland

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900190-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Specificity of human bactericidal antibodies against PorA P1.7,16 induced with a hexavalent meningococcal outer membrane vesicle vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900190-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Dynamics of carriage of Neisseria meningitidis in a group of military recruits: subtype stability and specificity of the immune response following colonization

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900190-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Antibodies to meningococcal class 1 outer-membrane protein and its variable regions in patients with systemic meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900190-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The class 1 outer membrane protein of Neisseria meningitidis: gene sequence and structural and immunological similarities to gonococcal porins

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900190-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Class 1 outer membrane protein of Neisseria meningitidis: epitope analysis of the antigenic diversity between strains, implications for subtype definition and molecular epidemiology

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900190-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Protective efficacy of monoclonal antibodies to class 1 and class 3 outer membrane proteins of Neisseria meningitidis B:15:P1.16 in infant rat infection model: new prospects for vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900190-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Production, characterization and control of a Neisseria meningitidis hexavalent class 1 outer membrane protein containing vesicle vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900190-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I clinical trial with a hexavalent PorA containing meningococcal outer membrane vesicle vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900190-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunization with synthetic peptides containing epitopes of the class 1 outer-membrane protein of Neisseria meningitidis: production of bactericidal antibodies on immunization with a cyclic peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900190-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunization with a multiple antigen peptide containing defined B- and T-cell epitopes: production of bactericidal antibodies against group B Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900190-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Antibody response of pregnant women to two different absorbed tetanus toxoids

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900190-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjuvant formulation for use in vaccines to elicit both cell-mediated and humoral immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900190-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The influence of different adjuvants on the immune response to a synthetic peptide comprising amino acid residues 9-21 of herpes simplex virus type 1 glycoprotein D.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900190-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunization with recombinant class 1 outer-membrane protein from Neisseria meningitidis: influence of liposomes and adjuvants on antibody avidity, recognition of native protein and the induction of a bactericidal immune response against meningococc

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900190-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjuvant activity of non-ionic block copolymers. V. Modulation of antibody isotype by lipopolysaccharides, lipid A and precursors

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900190-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Examination of the differential characteristics of amplifier and contrasuppressor T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900190-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Influence of adjuvants on the quantity, affinity, isotype and epitope specificity of murine antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900190-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Kinetic analysis of monoclonal antibody-antigen interactions with a new biosensor based analytical system

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900190-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase 1 clinical tests of influenza MDP-virosome vaccine (KD-5382).

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900190-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety, immunogenicity, and efficacy of a malaria sporozoite vaccine administered with monophosphoryl lipid A, cell wall skeleton of mycobacteria, and squalane as adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900190-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Active specific immunotherapy of metastatic melanoma with an antiidiotype vaccine: a phase I/II trial of I-Mel-2 plus SAF-m

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900190-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and immunogenicity of a hepatitis B vaccine formulated with a novel adjuvant system

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900190-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0264-410X(99)00190-5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10501243%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10501243%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40796063&oldid=1775316249"